RekrutujeFaza III
Study of Oral Deucrictibant XR Tablet for Prophylaxis and Deucrictibant Soft Capsule for On-Demand Treatment of Angioedema Attacks in Adults With Acquired Angioedema Due to C1…
Miasta: KrakówWiek: od 18 latSponsor: Pharvaris Netherlands B.V.
RekrutujeFaza I/II
EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid…
Miasta: Kraków, Szczecin, ŁódźWiek: od 18 latSponsor: Eikon Therapeutics Inc.
RekrutujeFaza III
A Phase III, randomized, open label, non-inferiority study comparing the efficacy and safety of furazidin vaginal tablets and clindamycin vaginal cream in the local treatment of…
Miasta: Białystok, Bydgoszcz, Będzin, Katowice i 5 innych miastWiek: 18-64 latSponsor: Adamed Pharma S.A.
RekrutujeFaza III
Long-term Efficacy and Safety Extension (LTE) Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria
Miasta: Białystok, Częstochowa, Elbląg, Gdańsk i 17 innych miastWiek: od 18 latSponsor: Celldex Therapeutics Inc.
RekrutujeFaza II
A Phase 2 Trial to Investigate Efficacy and Safety of Vipoglanstat in Women With Endometriosis
Miasta: Białystok, Bydgoszcz, Katowice, Kraków i 5 innych miastWiek: 18-64 latSponsor: Gesynta Pharma AB
RekrutujeFaza III
A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)
Miasta: Białystok, Bydgoszcz, Elbląg, Kraków i 10 innych miastWiek: od 18 latSponsor: Eli Lilly & Co.
Rekrutuje
Endo-ePIcardial Versus Endocardial Only Catheter Ablation for ISchemic Driven Ventricular Tachycardia (EPISODE VT)
Miasta: Bydgoszcz, Gdańsk, Kraków, Poznań i 2 inne miastaWiek: 18-85 latSponsor: MEDICOVER SP Z O.O.
RekrutujeFaza III
A Long-term Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder for Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease
Miasta: Białystok, Kraków, Lublin, WarszawaWiek: od 18 latSponsor: Insmed Inc.
RekrutujeFaza II/III
Framework for Optimizing, Refining, and Unifying Management of HSCT in Pediatric ALL
Miasta: Bydgoszcz, Kraków, Lublin, Poznań i 2 inne miastaWiek: do 64 latSponsor: Ospedale Pediatrico Bambino Gesu
RekrutujeFaza III
A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033)
Miasta: Bydgoszcz, Koszalin, Kraków, Przemyśl i 3 inne miastaWiek: od 18 latSponsor: Merck Sharp & Dohme LLC
RekrutujeFaza I
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
Miasta: Katowice, Kraków, Skórzewo, WarszawaWiek: od 18 latSponsor: Eli Lilly & Co.
RekrutujeFaza III
A Phase 3, Randomized, Open-label Study of Belzutifan + Zanzalintinib Versus Cabozantinib in Participants with Advanced RCC who Experienced Disease Recurrence During or After…
Miasta: Bydgoszcz, Koszalin, Kraków, Przemyśl i 3 inne miastaWiek: od 18 latSponsor: Merck Sharp & Dohme LLC
RekrutujeFaza III
Comparison of Weekly Somatrogon to Daily Genotropin in Children Born Small for Gestational Age or With Idiopathic Short Stature.
Miasta: Kraków, Rzeszów, Szczecin, Wrocław i 1 inne miastoWiek: do 17.99 latSponsor: Schneider Children's Medical Center Of Israel
RekrutujeFaza III
A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
Miasta: Bydgoszcz, Chojnice, Katowice, Kraków i 9 innych miastWiek: od 18 latSponsor: Novartis Pharma AG
RekrutujeFaza II
A Long Term Extension Study to Evaluate the Safety and Efficacy of Afimkibart (RO7790121) in Participants With Atopic Dermatitis
Miasta: Gdynia, Katowice, Kraków, Rzeszów i 4 inne miastaWiek: od 18 latSponsor: F. Hoffmann-La Roche AG
RekrutujeFaza III
A Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Subcutaneous Sonelokimab in Participants With Psoriatic Arthritis
Miasta: Białystok, Bydgoszcz, Bytom, Częstochowa i 20 innych miastWiek: od 18 latSponsor: MoonLake Immunotherapeutics AG
RekrutujeFaza I/II
A Phase 1b/2a Open-Label Dose-Finding Followed by Randomized, Double-Blind, Placebo-Controlled Expansion Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of…
Miasta: Bydgoszcz, Katowice, KrakówWiek: od 18 latSponsor: TargED Biopharmaceuticals B.V.
RekrutujeFaza III
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Miasta: Katowice, Koszalin, Kraków, Opole i 1 inne miastoWiek: od 18 latSponsor: Pfizer Inc.
RekrutujeFaza III
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic…
Miasta: Katowice, Kielce, Kraków, Lublin i 5 innych miastWiek: od 18 latSponsor: Pfizer Inc.
RekrutujeFaza III
A Study to Learn About Salanersen's (BIIB115) Effects on Movement and Its Safety When Given Before Symptoms Appear in Babies With Genetically Diagnosed Spinal Muscular Atrophy…
Miasta: Kraków, WarszawaWiek: do 64 latSponsor: Biogen Idec Research Limited
RekrutujeFaza II/III
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously…
Miasta: Brzozów, Gdańsk, Gliwice, Jelenia Góra i 5 innych miastWiek: od 18 latSponsor: Bristol-Myers Squibb Services Unlimited Company
RekrutujeFaza III
A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)
Miasta: Koszalin, Kraków, Olsztyn, Warszawa i 1 inne miastoWiek: od 18 latSponsor: AstraZeneca AB
RekrutujeFaza III
A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
Miasta: Katowice, Kraków, Lublin, Mysłowice i 4 inne miastaWiek: od 18 latSponsor: Glaxosmithkline Research & Development Limited
RekrutujeFaza III
A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
Miasta: Katowice, Kraków, Lublin, Mysłowice i 4 inne miastaWiek: od 18 latSponsor: Glaxosmithkline Research & Development Limited
RekrutujeFaza III
A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)
Miasta: Kraków, Poznań, Szczecin, Warszawa i 2 inne miastaWiek: od 0 latSponsor: Boehringer Ingelheim International GmbH, Boehringer…
RekrutujeFaza II
A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma
Miasta: Kraków, PoznańWiek: 18-64 latSponsor: Eli Lilly & Co.
RekrutujeFaza III
A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Palmoplantar Pustulosis
Miasta: Białystok, Gdańsk, Katowice, Kraków i 7 innych miastWiek: od 18 latSponsor: UCB Biopharma
RekrutujeFaza III
A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-038)
Miasta: Kraków, OtwockWiek: od 18 latSponsor: Merck Sharp & Dohme LLC
RekrutujeFaza III
A Study to Investigate Bowel Cleansing With PLENVU® Compared to Sodium Picosulfate in Participants Aged 1 to < 18 Years of Age in Preparation for Colonoscopy
Miasta: Białystok, Gdańsk, Kraków, Toruń i 2 inne miastaWiek: do 17.99 latSponsor: Norgine Limited
RekrutujeFaza III
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Miasta: Bydgoszcz, Koszalin, Kraków, Skórzewo i 3 inne miastaWiek: od 18 latSponsor: Eli Lilly & Co.